Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Pharmaron, China’s third-largest CRO, announced a...
Fosun Pharma expects tor raise $600 million in its...
Innovent Biologics, a Suzhou company formed last year, is...
WuXi PharmaTech, a CRO known mostly for its pre-clinical...
WuXi PharmaTech is forming a JV with PRA, a US-based...
Sinopharm Holdings, one of China’s big-three drug...
Syros Pharmaceuticals of Boston raised $30 million to...
Shanghai Fosun Pharma, Chindex and a private equity...
RuiYi Inc., a San Diego-Shanghai biotech, signed an...
Zhejiang Medicine Co. formed a collaboration with Ambrx...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
